Neonatal abstinence syndrome: paediatric case report
| dc.contributor.author | Maddocks, Neil | |
| dc.date.accessioned | 2023-04-01T13:22:30Z | |
| dc.date.available | 2023-04-01T13:22:30Z | |
| dc.date.issued | 2023-03-02 | |
| dc.identifier.citation | Maddocks, N., 2023. Neonatal abstinence syndrome: paediatric case report. Journal of Paramedic Practice, 15 (3), 100-104. | en_US |
| dc.identifier.issn | 1759-1376 | |
| dc.identifier.issn | 2041-9457 | |
| dc.identifier.doi | 10.12968/jpar.2023.15.3.100 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12417/1394 | |
| dc.description.abstract | Neonatal abstinence syndrome (NAS) is a severe life-threatening condition, characterised as a spectrum of clinical manifestations observed in neonates where maternal opioid use, both prescribed and illicit, has taken place during pregnancy. This article was written after experience of the condition identified a learning outcome, a potential change in practice, and the differences between out-of-hospital and in-hospital managements of NAS. In addition, this article will aim to identify the complications of NAS, the severity of the condition, and the varying methods of treatment. Abstract published with permission. | |
| dc.language.iso | en | en_US |
| dc.subject | Emergency Medical Services | en_US |
| dc.subject | Neonatal Abstinence Syndrome | en_US |
| dc.subject | Naxolone | en_US |
| dc.subject | Paediatrics | en_US |
| dc.subject | Respiration | en_US |
| dc.title | Neonatal abstinence syndrome: paediatric case report | en_US |
| dc.source.journaltitle | Journal of Paramedic Practice | en_US |
| dcterms.dateAccepted | 2023-03-07 | |
| rioxxterms.version | NA | en_US |
| rioxxterms.licenseref.startdate | 2023-03-07 | |
| rioxxterms.type | Journal Article/Review | en_US |
| refterms.panel | Unspecified | en_US |
| refterms.dateFirstOnline | 2023-03-02 | |
| html.description.abstract | Neonatal abstinence syndrome (NAS) is a severe life-threatening condition, characterised as a spectrum of clinical manifestations observed in neonates where maternal opioid use, both prescribed and illicit, has taken place during pregnancy. This article was written after experience of the condition identified a learning outcome, a potential change in practice, and the differences between out-of-hospital and in-hospital managements of NAS. In addition, this article will aim to identify the complications of NAS, the severity of the condition, and the varying methods of treatment. Abstract published with permission. | en_US |